We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparative Physiologic Technology Study

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2010 by Massachusetts General Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01126788
First Posted: May 20, 2010
Last Update Posted: November 24, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Massachusetts General Hospital
May 18, 2010
May 20, 2010
November 24, 2010
December 2009
December 2011   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01126788 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparative Physiologic Technology Study
Comparative Physiologic Technology Study

This study is designed to test two hypotheses:

  1. The PADnet+ testing system produces clinically equivalent results as the Parks Flo-Lab testing system in a group of patients referred for evaluation of PAD of the limbs when performed by a Registered Vascular Technologist (RVT).
  2. The PADnet+ testing system produces clinically equivalent results when the testing is repeated on the above patients and performed by staff specifically trained on the use of the PADnet+ system but are not vascular technologists nor hold the RVT certification.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
All patients referred to the MGH Vascular Labs for diagnostic testing for PAD
Peripheral Arterial Disease
Not Provided
  • PADnet + testing
  • Parks Flo-lab Test
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
100
December 2011
December 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients referred to the MGH Vascular Labs for diagnostic testing for PAD

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01126788
2009P002554
No
Not Provided
Not Provided
Glenn LaMuraglia, MD, Massachusetts General Hospital
Massachusetts General Hospital
Not Provided
Principal Investigator: Glenn LaMuraglia, MD Massachusetts General Hospital
Massachusetts General Hospital
November 2010